Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Percutaneous thermal ablation of hepatic tumors is accepted as a safe, reliable, and cost-effective therapeutic option for treating hepatocellular carcinoma and hepatic metastases. However, operators should be familiar with the myriad of vascular and non-vascular complications that can occur post-ablation and that are described in the literature. This review will focus on the various vascular complications related to percutaneous thermal ablation of hepatic tumors and discuss strategies to avoid and manage these complications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679696 | PMC |
| http://dx.doi.org/10.5152/dir.2022.21809 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
New Trends in Thyroid Malignancy: Minimally Invasive Thermal Ablation Percutaneous Techniques for T1 Papillary Thyroid Carcinomas.
Curr Oncol
August 2025
IMASUD Diagnostic and Interventional Radiology Group, PolyClinique les Fleurs, Quartier Quiez, ELSAN MEDIPOLE SUD, 83189 Ollioules, France.
During the late 1990s, thyroid nodule management strongly improved with the development of high-frequency ultrasound (HFUS) and US-guided percutaneous procedures [...
View Article and Find Full Text PDFPercutaneous Peripheral Nerve Stimulation in Chemotherapy-Induced Neuropathy: A Case Report.
Reports (MDPI)
August 2025
Institute for Health Research Aragon, Faculty of Health Sciences, University of Zaragoza, 50009 Zaragoza, Spain.
: Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and limiting complication of oncological treatment, particularly in patients receiving oxaliplatin. Its onset can significantly affect the quality of life and compromise the continuity of the antineoplastic therapy. Due to the limited efficacy of available pharmacological therapies, percutaneous electrical nerve stimulation (PENS) has been proposed as a non-invasive alternative for symptom management.
View Article and Find Full Text PDFMultiphase MRI-Derived Delta radiomics integrated with clinical features for survival prediction in hepatocellular carcinoma after thermal ablation.
Eur J Radiol
August 2025
Department of Radiology, Huaihe Hospital, Henan University, No. 8 Baobei Road, Gulou District, Kaifeng City 475000 Henan province, China.
Rationale And Objectives: To evaluate the predictive value of a delta radiomic score (DRS)derived from multiphase contrast-enhanced Magnetic Resonance Imaging (MRI), in combination with clinical characteristics, forecasting overall survival (OS) and recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) after thermal ablation.
Materials And Methods: This retrospective study enrolled 415 patients with HCC from two centers who underwent multiphase contrast-enhanced magnetic resonance imaging and percutaneous thermal ablation. Patients in Institution 1 (n = 315) were randomly assigned to the training cohorts (n = 220) and internal tests (n = 95), while 100 patients in Institution 2 formed the external validation cohort.
First-in-Human Clinical Feasibility Study of Ablation of Benign Thyroid Nodules Using Nanosecond Pulsed Field Ablation.
Thyroid
August 2025
Pulse Biosciences, Inc., Hayward, California, USA.
Thyroid nodules are common in the general population, and most are benign. Thyroidectomy remains the most common treatment for symptomatic benign thyroid nodular disease. The objective of this study is to determine if a novel, cell-specific, nonthermal modality called nanosecond pulsed field ablation (nsPFA) can provide a safe and effective treatment for symptomatic thyroid nodules.
View Article and Find Full Text PDFPercutaneous Thermal Ablation for Early-Stage Breast Cancer: An Open-Label, Randomized, Phase II Trial to Select the Preferred Technique for Evaluating Thermal Ablation as a Surgical Alternative.
Radiology
August 2025
Department of Surgery, Franciscus Gasthuis & Vlietland, Kleiweg 500, 3045 PM Rotterdam, the Netherlands.